INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 41 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $995 | -11.2% | 3,955 | 0.0% | 0.00% | – |
| Q2 2020 | $1,120 | +43.8% | 3,955 | 0.0% | 0.00% | – |
| Q1 2020 | $779 | -60.6% | 3,955 | 0.0% | 0.00% | – |
| Q4 2019 | $1,978 | -31.4% | 3,955 | 0.0% | 0.00% | – |
| Q3 2019 | $2,883 | -78.4% | 3,955 | +28.6% | 0.00% | -100.0% |
| Q2 2019 | $13,346 | -21.0% | 3,075 | +33.4% | 0.00% | -50.0% |
| Q1 2019 | $16,896 | +26.6% | 2,305 | +30.2% | 0.00% | 0.0% |
| Q4 2018 | $13,346 | – | 1,770 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,125,153 | $4,951,000 | 3.63% |
| ACUTA CAPITAL PARTNERS, LLC | 2,962,568 | $13,035,000 | 2.32% |
| DAFNA Capital Management LLC | 568,600 | $2,502,000 | 1.17% |
| MEITAV INVESTMENT HOUSE LTD | 2,450,592 | $11,425,000 | 0.51% |
| SECTORAL ASSET MANAGEMENT INC | 890,386 | $3,918,000 | 0.44% |
| Avoro Capital Advisors LLC | 2,570,705 | $11,311,000 | 0.44% |
| Cormorant Asset Management, LP | 773,816 | $3,405,000 | 0.25% |
| CAXTON CORP | 64,817 | $285,000 | 0.10% |
| Migdal Insurance & Financial Holdings Ltd. | 522,067 | $2,297,000 | 0.06% |
| 683 Capital Management, LLC | 150,000 | $660,000 | 0.04% |